Skip to content

13F-HR filed by Temasek Holdings (Private) Ltd

Temasek Holdings (Private) Ltd filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-14, with 39 holding rows worth $12,494,919,000.

Accession
0001104659-17-008777
Filed
2017-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2016

A holdings report, 39 entries on the cover page, a total value of $12,494,919,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $12,494,917,000 with VALUE read as thousands by filing date, 13F file number 028-13088. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerAranda Investments Pte. Ltd. 028-17255
  • included managerCairnhill Investments (Mauritius) Pte Ltd 028-13098
  • included managerDahlia Investments Pte. Ltd. 028-15196
  • included managerDunearn Investments (Mauritius) Pte Ltd 028-14160
  • included managerEsta Investments Pte. Ltd. 028-15912
  • included managerEvans Investments Pte. Ltd. 028-17259
  • included managerFullerton Fund Investments Pte Ltd 028-15193
  • included managerFullerton Management Pte Ltd 028-13103
  • included managerHavelock Fund Investments Pte Ltd 028-15197
  • included managerIxora Investments Pte. Ltd. 028-17256
  • included managerMaxwell (Mauritius) Pte Ltd 028-15904
  • included managerNormanton Investments Pte. Ltd.
  • included managerNorthbrooks Investments (Mauritius) Pte Ltd 028-14158
  • included managerSeletar Investments Pte Ltd 028-13095
  • included managerSennett Investments (Mauritius) Pte Ltd 028-15194
  • included managerTemasek Capital (Private) Ltd 028-13090
  • included managerTemasek Life Sciences Private Ltd 028-15907
  • included managerTembusu Capital Pte. Ltd. 028-14163
  • included managerThomson Capital Pte. Ltd. 028-15195
  • included managerV-Sciences Investments Pte Ltd 028-15905

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LEVEL 3 COMMUNICATIONS INC52729N308COM NEW65,031,667$3,665,185,000thousands by filing date
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS35,495,289$3,116,842,000thousands by filing date
Gilead Sciences,Inc.375558103COM13,830,516$990,403,000thousands by filing date
IHS MARKIT LTDG47567105SHS21,173,310$749,747,000thousands by filing date
UNIVAR INC91336L107COMMON STOCK18,165,603$515,358,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM2,899,315$409,093,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM3,472,712$287,679,000thousands by filing date
TURQUOISE HILL RESOURCES LTD900435108COMMON STOCK-FO73,213,884$236,481,000thousands by filing date
ANTERO RESOURCES CORP COM03674X106Stock9,755,618$230,720,000thousands by filing date
PAYPALHLDGSINC70450Y103STOK5,387,963$212,663,000thousands by filing date
VIRTU FINL INC928254101CL A12,317,682$196,467,000thousands by filing date
CTRIP COM INTL LTD22943F100AMERICAN DEP SHS4,777,235$191,089,000thousands by filing date
JD.COM INC SPON ADS CL A47215P106ADR7,306,572$185,879,000thousands by filing date
PPG INDS INC COM693506107Stock1,668,478$158,105,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM1,226,630$150,078,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock6,583,568$147,735,000thousands by filing date
ZTO EXPRESS CAYMAN INC98980A105SPONSORED ADS A12,176,750$146,973,000thousands by filing date
Visa Inc92826C839COM1,522,287$118,769,000thousands by filing date
ATHENE HOLDING LTDG0684D107CL A2,312,694$110,986,000thousands by filing date
Amazon.com, Inc023135106COM128,970$96,711,000thousands by filing date
DELL TECHNOLOGIES INC CLASS CLASS C24703L103CLASS C1,576,167$86,642,000thousands by filing date
VNET GROUP INC90138A103SPONSORED ADS A10,778,004$75,554,000thousands by filing date
TUNIU CORP89977P106SPONSORED ADS8,194,444$71,701,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock126,351$46,382,000thousands by filing date
AMYRIS INC03236M101COM61,121,718$44,619,000thousands by filing date
SYNCHRONYFINL87165B103STOK1,118,320$40,561,000thousands by filing date
EROS INTL PLCG3788M114SHS NEW2,755,310$35,957,000thousands by filing date
ILLUMINA INC452327109COM277,261$35,500,000thousands by filing date
MasterCard, Inc57636Q104COM267,006$27,568,000thousands by filing date
ROYAL DUTCH SHELL PLC SPN ADR780259107SPON ADR B408,543$23,683,000thousands by filing date
ICICI BANK LIMITED ADR45104G104ADR2,553,625$19,127,000thousands by filing date
AC IMMUNE SAH00263105SHS1,337,500$17,361,000thousands by filing date
JUNO THERAPEUTICS INC48205A109COM915,750$17,262,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR380,000$11,537,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM790,527$10,364,000thousands by filing date
AMYRIS INC03236MAC5NOTE 6.500 5/110,000,000$6,800,000thousands by filing dateprincipal
MARIN SOFTWARE INC56804T106COM2,528,205$5,941,000thousands by filing date
NQ MOBILE INC64118U108ADR REPR CL A243,458$784,000thousands by filing date
COGNIZANT TECHNOLOGY SOLUTIONS CL A192446102Stock10,900$611,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-17-008777this filing2017-02-14acceptance time not in the bulk data set